Literature DB >> 18024261

Meta-analysis of tumor recurrence after liver transplantation for hepatocellular carcinoma based on 1,198 cases.

Georgios C Sotiropoulos1, E P Molmenti, C Lösch, S Beckebaum, C E Broelsch, H Lang.   

Abstract

BACKGROUND: The purpose of this study was to systematically review tumor characteristics leading to recurrence of hepatocellular carcinoma (HCC) after liver transplantation (LT).
MATERIAL AND METHODS: A computer search of the Medline database was carried out. Tumor characteristics examined were: 1) no vascular versus vascular invasion, 2) solitary versus multifocal tumors, 3) well differentiated versus not well differentiated HCCs, 4) HCC meeting versus HCC exceeding the Milan criteria, 5) HCC < or =5 cm versus HCC>5 cm.
RESULTS: Of 45 clinical studies screened, 9 fulfilled the study criteria. These studies included from 21 to 316 patients, for a total of 1198 patients. A fixed effects model was applied. A significant correlation between vascular invasion, not well differentiated HCC, tumor size >5 cm, HCC exceeding the Milan criteria, and HCC recurrence post transplant was shown (common odds ratio of 8.727, 2.89, 13.32 and 4.205, respectively). Heterogeneity for the parameter solitary versus multifocal tumor was shown.
CONCLUSION: High risk pathology for HCC recurrence is characterized by not well differentiated tumors and by HCCs that exceed the Milan criteria. A clinical application of these data may be a scoring system which includes the tumor grading in the evaluation and listing of HCC patients to LT.

Entities:  

Mesh:

Year:  2007        PMID: 18024261

Source DB:  PubMed          Journal:  Eur J Med Res        ISSN: 0949-2321            Impact factor:   2.175


  32 in total

1.  Monitoring for post-transplant hepatocellular carcinoma recurrence.

Authors:  Jorge Ortiz; Jennifer Danniel; Mariana Chavez; Giovanni Davogustto
Journal:  HPB (Oxford)       Date:  2012-03-11       Impact factor: 3.647

2.  Percentage of signal intensity loss for characterisation of focal liver lesions in patients with chronic liver disease using ferucarbotran-enhanced MRI.

Authors:  C-T Chou; R-C Chen; W-T Chen; J-M Lii
Journal:  Br J Radiol       Date:  2010-04-22       Impact factor: 3.039

Review 3.  Liver transplantation for hepatocellular carcinoma: role of inflammatory and immunological state on recurrence and prognosis.

Authors:  Matteo Cescon; Valentina Rosa Bertuzzo; Giorgio Ercolani; Matteo Ravaioli; Federica Odaldi; Antonio Daniele Pinna
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

4.  Hepatocellular carcinoma (HCC) recurrence and what to do when it happens.

Authors:  Adam S Bodzin
Journal:  Hepatobiliary Surg Nutr       Date:  2016-12       Impact factor: 7.293

Review 5.  Optimization of immunosuppressive medication upon liver transplantation against HCC recurrence.

Authors:  Shirin Elizabeth Khorsandi; Nigel Heaton
Journal:  Transl Gastroenterol Hepatol       Date:  2016-04-06

Review 6.  Hepatocellular Carcinoma and Liver Transplantation: Changing Patterns and Practices.

Authors:  Nicole E Rich; Neehar D Parikh; Amit G Singal
Journal:  Curr Treat Options Gastroenterol       Date:  2017-06

7.  Imaging follow-up after liver transplantation.

Authors:  Michele Di Martino; Massimo Rossi; Gianluca Mennini; Fabio Melandro; Michele Anzidei; Silvia De Vizio; Kameliya Koryukova; Carlo Catalano
Journal:  Br J Radiol       Date:  2016-06-10       Impact factor: 3.039

Review 8.  Liver transplantation for hepatocellular carcinoma - factors influencing outcome and disease-free survival.

Authors:  René Fahrner; Felix Dondorf; Michael Ardelt; Yves Dittmar; Utz Settmacher; Falk Rauchfuß
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

Review 9.  Impact of non-oncological factors on tumor recurrence after liver transplantation in hepatocellular carcinoma patients.

Authors:  Xiang-Qian Gu; Wei-Ping Zheng; Da-Hong Teng; Ji-San Sun; Hong Zheng
Journal:  World J Gastroenterol       Date:  2016-03-07       Impact factor: 5.742

10.  Living donor liver transplantation for hepatocellular carcinoma at the University of Tokyo Hospital.

Authors:  Junichi Togashi; Nobuhisa Akamastu; Norihiro Kokudo
Journal:  Hepatobiliary Surg Nutr       Date:  2016-10       Impact factor: 7.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.